The outlook downgrade was based on a number of factors, including the decline in Houston Healthcare’s operating margins through the first nine months of fiscal year 2014. The system’s operating cash flow also declined during that time.
Competition in Houston Healthcare’s primary service area and the system’s year-over-year decline in outpatient surgeries also contributed to the outlook revision. From fiscal year 2009 to fiscal year 2013, surgeries were down 37.6 percent at Houston Healthcare.
The system’s strengths such as having the only acute-care hospitals in HoustonCounty were also considered for the credit rating affirmation and the outlook revision.
More articles on healthcare finance:
For-profit hospital stock report: Week of Dec. 8-12
Hospitals have 70% overturn rate when appealing RAC claims
CHI posts $134.7M operating loss in Q1 of 2015
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
